Mold & CIRS Track · Webinar 3 of 4
Low testosterone associated with mold: the cause TRT doesn't fix
A man in his thirties with total testosterone in the 200s, normal LH, no pituitary lesion, and a doctor whose only offer is TRT — that is the case this session is about.
In biotoxin illness, androgen suppression is a downstream consequence of inflammation, not a primary gonadal failure. Elevated MMP-9 and TGF-β1, suppressed MSH, and disordered ADH/osmolality change how androgens are produced and converted. Replacing the end hormone leaves the driver running.
Dr. Nicole walks through the pattern, the labs that reveal it, and when TRT is still the right call — because sometimes it is, just not as the whole plan.
Loading webinar…
This session is for you if…
- Total testosterone is low but LH and FSH look unremarkable
- TRT gave you six good weeks and then flattened out
- Low libido and low motivation alongside brain fog or air hunger
- Symptoms started after moving into a new home, office, or basement gym
- Estradiol keeps climbing on replacement despite dose adjustments
What the webinar covers
- How biotoxin inflammation suppresses androgen production upstream of the gonads
- The MMP-9 / TGF-β1 / MSH pattern that shows up in mold-driven low T
- Why aromatase behaves differently in an inflamed, mold-exposed body
- When TRT is appropriate alongside a biotoxin protocol — and when it delays recovery
- The sequence: exposure, inflammation, then hormones
Find out if this is your root cause
A $47 Health Decode maps your root-cause picture before you spend on specialty panels — so you know which thread to pull first.
Frequently asked questions
Next reading
MMP-9, TGF-β1 and MSH are the three that drive the androgen picture.
Androgen correction is step 6 of the protocol. Here is the full sequence.
Two ways to sequence the same problem — and which fits a fragile patient.
Prefer the library view? Open this session in the webinar library.
More in the mold, CIRS & Klinghardt cluster
Automatically matched to the topics in this session.
The biomarker-defined inflammatory cascade behind most unresolving mold illness.
ContinueWhy mycotoxin exposure drives estrogen dominance, PCOS-like patterns, infertility and Hashimoto's — and the testing orde
ContinueExposure review, mycotoxin and CIRS interpretation, sequenced protocols. Virtual across the US.
ContinueSide-by-side on biomarkers, sequencing, binders, cost and who each one suits.
ContinueC4a, TGF-β1, MMP-9, MSH, VIP, VEGF, MARCoNS, HLA-DR — what each result changes.
ContinueAll 12 steps in order, what each one does, and the three places patients stall.
ContinueEducational content only. Biotoxin and hormone protocols require clinician supervision and are not a diagnosis or treatment plan.